Neurizon Therapeutics names Dr. Chris Bremer as Chief Executive Officer

MELBOURNE: Neurizon Therapeutics Ltd., a late-stage biotechnology company focused on neurodegenerative diseases, has appointed Dr. Chris Bremer as chief executive officer, effective Oct. 1. Bremer, who holds an M.D., Ph.D. and MBA, brings more than 20 years of international pharmaceutical and biotechnology leadership to the role, a statement noted. His career includes senior global executive positions at Grünenthal,…